The significant potency of IL-38, together with the broad anti-inflammatory properties of IL-37 and its natural presence in the human body, indicates that therapies utilizing these cytokines may offer effective and safe therapeutic alternatives for individuals with autism (47, 135, 136). This evidence concerns the gene IL1F10 and autism.